logo
Select company
Select metric
$ -4.83MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
30
Sector
69
Industry
34
History
98
$ 4.72Close
$ 2.07 - $ 7.08 52-Week Range
Ticker Information

Ticker

EVOK

Company Name

EVOKE PHARMA INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

EVOKE PHARMA INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

EVOK - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 51.06K$ -4.88M$ -4.83M
3/31/2025$ 31.91K$ -4.58M$ -4.55M
12/31/2024$ 12.76K$ -4.85M$ -4.84M
9/30/2024$ 13.37K$ -5.65M$ -5.63M
6/30/2024$ 52.84K$ -6.03M$ -5.97M
3/31/2024$ 91.4K$ -6.63M$ -6.54M
12/31/2023$ 129.07K$ -7.29M$ -7.16M
9/30/2023$ 140.3K$ -7.11M$ -6.97M
6/30/2023$ 113.26K$ -7.43M$ -7.31M
3/31/2023$ 74.7K$ -7.79M$ -7.72M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • EVOKE PHARMA INC's latest trailing twelve months (TTM) EBITDA stands at $ -12.25M.
  • Over the past 5 years, EVOKE PHARMA INC's average EBITDA has been $ -7.83M.
  • The median EBITDA for EVOKE PHARMA INC during this period was $ -7.56M
  • EVOKE PHARMA INC reached its highest EBITDA over the past 5 years at $ -4.55M.
  • The lowest EBITDA recorded by EVOKE PHARMA INC in the same timeframe $ -13.73M

EVOKE PHARMA INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
SNOA : SONOMA PHARMACEUTICALS INC $ -3.02MYCBD : CBDMD INC $ -104.85KMSPR : MSP RECOVERY INC $ -117.28MCPHI : CHINA PHARMA HOLDINGS INC $ -1.74MBIAF : BIOAFFINITY TECHNOLOGIES INC $ -11MTLPH : TALPHERA INC $ -11.3MJAGX : JAGUAR HEALTH INC $ -38.7MIVF : INVO FERTILITY INC $ -26.06MCARM : CARISMA THERAPEUTICS INC $ -45.68MEKSO : EKSO BIONICS HOLDINGS INC $ -9.25M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for EVOKE PHARMA INC is calculated as follows: EBIT [ $ -12.25M ] + DepAmor [ $ 0 ]
(=) EBITDA [ $ -12.25M ]

EVOK - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -13.73M

Minimum

Mar 31, 2021

$ -4.55M

Maximum

Mar 31, 2025

$ -7.83M

Average

$ -7.56M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.87M with a standard deviation of $ 166.99M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.87M
median$ 8.87M
std$ 166.99M